Skip to main content
. 2022 Sep 7;58(9):1239. doi: 10.3390/medicina58091239
VEGFR vascular endothelial growth factor receptor
VEGF vascular endothelial growth factor
BRAF v-raf murine sarcoma viral oncogene homolog B1
ETC electron transport chain
OS overall survival
PFS progression-free survival
LKB1 liver kinase B1
DNA-PKcs DNA-dependent protein kinase, catalytic subunit
PI3K phosphoinositide 3-kinases
Akt serine-threonine protein kinase
MGMT O6-alkylguanine DNA alkyltransferase
NLRP3 nucleotide-binding oligomerization domain-like receptor pyrin domain-containing 3
FGFR3 fibroblast growth factor receptor 3
ARB adrenergic receptor
ESM-1 cancer progression-related protein level
PARP poly (ADP-ribose) polymerase
B-CPAP poorly differentiated thyroid gland carcinoma
Gli1 glioma-associated oncogene
Beta-AR beta-adrenergic receptor
EGFR endothelial growth factor receptor
Bcl2 B-cell lymphoma 2
TNIK TRAF2- and NCK-interacting protein kinase
AMPK adenosine monophosphate-activated protein kinase
HMG-CoA 3-hydroxy-3-methylglutaryl coenzyme A reductase
FDA US Food and Drug Administration
HER2 human epidermal growth factor receptor 2
IGF-I insulin-like growth factor I
TORC1 target of rapamycin complex 1
CSCs circulating tumor cells
Redd1 regulated in development and DNA damage responses 1
mTOR mammalian target of rapamycin
NF-κB nuclear factor kappa B
GSDMD gasdermin D
OCT3/4 octamer-binding transcription factor
COX-2 cyclooxygenase-2
IL-6 interleukin 6
CSS cancer-specific survival
Stat3 signal transducer and activator of transcription 3
ER estrogen receptor
DUSP1 dual specificity phosphatase 1
OxPhos oxidative phosphorylation
MSH2 MutS Homolog 2 protein-coding gene